Therapeutic Drug Monitoring: Empirical Evidence Catches up to Common Sense

Common sense might dictate that, in maintaining health and wellness, being proactive is generally better than being reactive. But the practice of medicine often demands more than just common sense. It demands data and evidence to support clinical decision making. The discussion of therapeutic drug monitoring in gastroenterology hinges on this conundrum. Proactive monitoring appears to be the common-sense approach, but the data supporting its use have not yet closed the case.At the moment, gastroenterologists largely use reactive therapeutic drug monitoring (TDM). Meaning, when a patientRead More

Share on facebook
Share on twitter
Share on linkedin